Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lannett gets USFDA nod for Butalbital, Acetaminophen and Caffeine Capsules

      Lannett gets USFDA nod for Butalbital, Acetaminophen and Caffeine Capsules

      Medical Dialogues Bureau27 Dec 2019 9:20 AM IST
      The two dosage strengths of BAC Capsules, have a combined estimated IQVIA market value of approximately $68.6 million for the 12 months ending October...
      Rational Use Of Antibiotics For Limiting Antimicrobial Resistance: CDSCO lists down steps for Pharma cos, chemists and drug controllers

      Rational Use Of Antibiotics For Limiting Antimicrobial Resistance: CDSCO lists down steps for Pharma cos, chemists and drug controllers

      Medical Dialogues Bureau26 Dec 2019 6:08 PM IST
      New Delhi: Through a recent notice, Dr VG Somani, Drugs Controller General (India) has listed down various steps that have to be taken by the relevant...
      Dishman Carbogen shares rise by 9 pc after I-T department conducts search at offices

      Dishman Carbogen shares rise by 9 pc after I-T department conducts search at offices

      Medical Dialogues Bureau26 Dec 2019 4:29 PM IST
      Ahmedabad: The share price of Dishman Carbogen Amcis rose by over 9 per cent on Thursday after officials of the Income Tax Department conducted search...
      Allergan signs $750 million settlement with purchasers of Alzheimer

      Allergan signs $750 million settlement with purchasers of Alzheimer's drug Namenda

      Medical Dialogues Bureau26 Dec 2019 2:24 PM IST
      NEW YORK: Purchasers of Allergan Plc's Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker...
      Piramal Enterprises to raise Rs 2,750 crore by issuing bonds on private placement basis.

      Piramal Enterprises to raise Rs 2,750 crore by issuing bonds on private placement basis.

      Medical Dialogues Bureau26 Dec 2019 2:23 PM IST
      Mumbai: Piramal Enterprises said on Wednesday that it will raise up to Rs 2,750 crore by issuing bonds on private placement basis."A meeting of the...
      Eurolife Healthcare acquires intravenous infusion business of Teva, Hungary

      Eurolife Healthcare acquires intravenous infusion business of Teva, Hungary

      Medical Dialogues Bureau26 Dec 2019 9:23 AM IST
      New Delhi: Drug firm Eurolife Healthcare on Tuesday said it has completed the acquisition of intravenous (IV) infusion business of Teva Pharmaceutical...
      Punjab: 50-year-old pharmacist harassed, blackmailed, extorted of Rs 6 lakh; constable held

      Punjab: 50-year-old pharmacist harassed, blackmailed, extorted of Rs 6 lakh; constable held

      Medical Dialogues Bureau25 Dec 2019 12:00 PM IST
      Punjab: A city-based pharmacist became a victim of extortion from none other than a police constable, who was recently arrested for taking Rs 6 lakh...
      Alembic Pharma glaucoma drug Travoprost Ophthalmic Solution gets USFDA approval

      Alembic Pharma glaucoma drug Travoprost Ophthalmic Solution gets USFDA approval

      Medical Dialogues Bureau25 Dec 2019 9:55 AM IST
      The USFDA approved Travoprost Ophthalmic Solution is a generic equivalent to Alcon Pharmaceuticals' Travatan Ophthalmic Solution, Alembic...
      Granules India gets USFDA nod for allergy treatment drug Loratadine

      Granules India gets USFDA nod for allergy treatment drug Loratadine

      Medical Dialogues Bureau25 Dec 2019 9:50 AM IST
      "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd, for Loratadine...
      Roche to pay USD 1.15 billion to Sarepta for gene therapy licensing deal

      Roche to pay USD 1.15 billion to Sarepta for gene therapy licensing deal

      Medical Dialogues Bureau25 Dec 2019 9:32 AM IST
      Roche will make an upfront payment of $750 million in cash and take a $400 million stake in Sarepta, priced at $158.59 per share, a premium of about...
      Merck KEYTRUDA gets Japanese nod for head, neck cancer

      Merck KEYTRUDA gets Japanese nod for head, neck cancer

      Medical Dialogues Bureau25 Dec 2019 9:30 AM IST
      New Delhi: Merck, known as MSD outside the United States and Canada, recently announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received new...
      Sick, loss-making Hindustan Antibiotics up for sale: Minister

      Sick, loss-making Hindustan Antibiotics up for sale: Minister

      Medical Dialogues Bureau24 Dec 2019 6:00 PM IST
      New Delhi: Loss making Hindustan Antibiotics Limited (HAL) is going to be sold off based on the recommendations of a Committee of Ministers.The...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok